News

Colli-Pee US FDA registered

Novosanis will present its VAX-ID™ device platform during BioJapan

Creating awareness

Prostate cancer is the most common male cancer, with around 400,000 new cases every year in Europe.

For a healthy life

Urology week is an initiative from the European Association for Urology (EAU) that tries to raise awareness for urological care and its importance in improving quality of life.

"High Frequency Ultrasound to Assess Skin Thickness in Healthy Adults” published in the prestigious peer-reviewed journal VACCINE.

This is the story of Michele Baldwin, a 45-year-old mother of three who was diagnosed with late-stage cervical cancer.

We're Hiring

GeneFirst Ltd collaborates with Novosanis

Novosanis is proud to announce that as from today its quality system is certified as compliant with the requirements of ISO13485 quality standards for manufacturers of medical devices.

Novosanis, a spin-off of the University of Antwerp, and DDL Diagnostic Laboratory investigated the detection of human papillomavirus (HPV) in first-void urine.